AVANIR Pharmaceuticals Presents Zenvia Phase III Safety Data At The American Academy Of Neurology Annual Meeting
Links shared publicly online about this topic.
- 1,232total visits
AVANIR Pharmaceuticals Presents Zenvia Phase III Safety Data At The American Academy Of Neurology Annual Meeting
AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) announced the presentation of detailed data, including safety and tolerability data from the open-label extension as well as cardiac safety data from the
View full resource at medicalnewstoday.com
Tags: Heart, Neurology, Pharma
Most Recently Shared on April 18, 2010 at 1:05 pm By:
AVANIR Pharmaceuticals Presents Zenvia Phase III Safety Data At The American Academy Of Neurology Annual Meeting http://mnt.to/3BnQ
Also Shared By:
Advertisement
MNT Neurology News
@mnt_neurology
AVANIR Pharmaceuticals Presents Zenvia Phase III Safety Data At The American Academy Of Neurology Annual Meeting http://mnt.to/3BnQ
1 year ago...